|
|
Article: Alcon scores legal victories in patent, trademark cases.(Travatan; Alcon Laboratories Inc.)
- Article from:
- Health & Medicine Week
- Article date:
- June 17, 2002
CopyrightCOPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2002 JUN 17 - (NewsRx.com & NewsRx.net) -- A federal court in New Jersey has rejected claims that Alcon Laboratories, Inc.'s, Travatan, its glaucoma medication approved by the FDA last year, violated any trademark rights of Pharmacia.
The court rebuffed a last minute effort by Pharmacia, the maker of a competing drug called Xalatan, to enjoin Alcon's sale of Travatan, which has been on the market and prescribed since March 2001. Alcon Laboratories is a subsidiary of Alcon, Inc.
Alcon also reported that, in an opinion rendered May 8, 2002, Judge David Carter of the United States District Court for the Central District of California, Southern Division ...